![Edward T. Samulski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Edward T. Samulski
Vorstandsvorsitzender bei Allotropica Technologies, Inc.
Profil
Edward T.
Samulski was the founder of Liquidia Technologies, Inc. (founded in 2004) and Carbon, Inc. (founded in 2013) where he held the title of Advisor.
He is currently the Chief Executive Officer at Allotropica Technologies, Inc. Dr. Samulski obtained a doctorate degree from Princeton University.
Aktive Positionen von Edward T. Samulski
Unternehmen | Position | Beginn |
---|---|---|
Allotropica Technologies, Inc.
![]() Allotropica Technologies, Inc. Medical/Nursing ServicesHealth Services Allotropica Technologies, Inc. engages in home healthcare services. The company was founded on July 29, 2008 and is headquartered in Chapel Hill, NC. | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Edward T. Samulski
Unternehmen | Position | Ende |
---|---|---|
Carbon, Inc.
![]() Carbon, Inc. Industrial MachineryProducer Manufacturing Carbon, Inc. engages in provision of digital manufacturing solutions. Its products include hardware, printing materials, and software. The company was founded by Edward T. Samulski, Steven Lars Nelson, Joseph M. DeSimone, Nikita Ermoshkin, and Alex Ermoshkin in 2013 and is headquartered Redwood City, CA. | Gründer | - |
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Gründer | - |
Ausbildung von Edward T. Samulski
Princeton University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Liquidia Technologies, Inc.
![]() Liquidia Technologies, Inc. Pharmaceuticals: MajorHealth Technology Liquidia Technologies, Inc. is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics using its proprietary PRINT technology to transform the lives of patients. It operates in two segments: Pharmaceutical Products and Partnering & Licensing. The two product candidates from its pipeline: LIQ861 for the treatment of pulmonary arterial hypertension and LIQ865 for the treatment of local post-operative pain. Liquidia Technologies was founded by Joseph M. DeSimone, Ashok K. Mendiratta, Edward T. Samulski, William R. Kenan, Ginger Denison and Jason Rolland in 2004 and is headquartered in Morrisville, NC. | Health Technology |
Carbon, Inc.
![]() Carbon, Inc. Industrial MachineryProducer Manufacturing Carbon, Inc. engages in provision of digital manufacturing solutions. Its products include hardware, printing materials, and software. The company was founded by Edward T. Samulski, Steven Lars Nelson, Joseph M. DeSimone, Nikita Ermoshkin, and Alex Ermoshkin in 2013 and is headquartered Redwood City, CA. | Producer Manufacturing |
Allotropica Technologies, Inc.
![]() Allotropica Technologies, Inc. Medical/Nursing ServicesHealth Services Allotropica Technologies, Inc. engages in home healthcare services. The company was founded on July 29, 2008 and is headquartered in Chapel Hill, NC. | Health Services |